Documents

Ideas Discussions Technicals Forecast Seasonals Options

Entrada Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Entrada Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 06, 2025

Slides

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

Jun 03, 2025

Slides

Q1 2025

May 07, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Feb 27, 2025

Slides

Earnings release8-K

Annual report10-K

Q3 2024

Nov 05, 2024

Slides

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 13, 2024

Quarterly report10-Q

Earnings release8-K

Corporate Presentation

Aug 12, 2024

Slides

Corporate Presentation

Jun 24, 2024

Slides

Q1 2024

May 07, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 13, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 07, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 08, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 10, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 06, 2023

Earnings release8-K

Annual report10-K

Q3 2022

Nov 07, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 11, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 12, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 15, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Dec 09, 2021

Quarterly report10-Q

Earnings release8-K